ASTEC718.10

Astec LifeSciences Limited

· Chemicals
₹ CrorePeersPUNJABCHEMMOLIPLINSECTICIDDHARMAJBHARATRASADVANCEHERANBAMcap ₹1,600 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×0.760.961.001.00
Interest Burden (Pretax/EBIT) ×1.461.281.641.72
EBIT Margin %-9.20-28.83-11.03-8.78
Asset Turnover ×0.470.430.480.48
Financial Leverage (Assets/Equity) ×2.643.752.412.41
ROE (5-step product) %-12.69-56.98-20.87-17.47
ROE (reported, avg-equity basis) %-12.70-57.34-20.70-20.70
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.